Document is current
Any future updates will be listed below
-
Authors
Ma, Shenghong https://orcid.org/0000-0002-6335-7715
Tang, Tracy
Probst, Gary
Konradi, Andrei
Jin, Chunyu
Li, Fulong
Gutkind, J. Silvio
Fu, Xiang-Dong https://orcid.org/0000-0001-5499-8732
Guan, Kun-Liang https://orcid.org/0000-0003-1892-0174
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA217642, GM051586)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 23 August 2021
Accepted: 1 February 2022
First Online: 25 February 2022
Change Date: 4 August 2022
Change Type: Update
Change Details: In the original version of this article, the given and family names of J. Silvio Gutkind were incorrectly structured. The name was displayed correctly in all versions at the time of publication. The original article has been corrected.
Competing interests
: K.-L.G. is a cofounder of and has equity interest in Vivace Therapeutics. T.T., G.P. and A.K. are Vivace employees. The other authors declare no competing interests.
